the package insert of the medicine Ritmoneuran. Therapeutic class of Herbal. Active principles dry Extract of Passiflora incarnata.
Ritmoneuran capsule or oral solution is indicated to treat states of irritability, agitation, nervosa, treatment of insomnia and disorders of anxiety.
adult Use – oral Use
When should I not use?
Patients with a history of hypersensitivity and allergy to any of the components of the formula shall not make use of this product.
Women who are pregnant or nursing, should not use this medicine without medical advice.
This medicine should not be used together with alcoholic beverages. It should also not be associated with other drugs with sedative effect, hypnotic and anti-histamine.
Children under 12 years should not use this medicine without medical advice.
How to use?
to Ingest 2 capsules, 2 to 3 times a day (every 8 to 12 hours).
daily maximum: 6 capsules, or, 1.097,58 mg of dry Extract of Passiflora incarnata, equivalent to 38.4 mg of total flavonoids expressed in vitexina.
Ritmoneuran oral solution
Drink 10 to 15 mL of oral solution or 1 flaconete 10mL, 2 to 3 times a day (every 8 to 12 hours).
daily maximum: 45 mL, that is, 1.575 mg of dry Extract of Passiflora incarnata, equivalent to 63 mg of total flavonoids expressed in vitexina
there is No restriction to the duration of treatment.
What are the evils that can cause me?
At the recommended doses there are no known adverse effects to the medicine.
Rarely can occur adverse reactions such as nausea, vomiting, headache, and tachycardia.
excessive Doses may cause sedation prolonged and states of drowsiness.
Warnings and Precautions
what should I know before using?
In cases of hypersensitivity to the product, it is recommended to discontinue the use and consult the doctor.
do Not take larger doses than recommended.
This medicine should not be used together with alcoholic beverages, the face of the potentiation of their effects.
it Can occur drowsiness during the treatment. In this case the patient should not drive vehicles or operate machinery, since the skill and attention may be reduced.
Ritmoneuran in pregnancy: according to the risk category of drugs intended for pregnant women, this drug presents the risk category C. This medicine should not be used by pregnant women without medical or dental surgeon.
This drug potentiates the sedative effects of pentobarbital and hexobarbital, increasing the sleep time of patients.
There are indications that the present in the plant species present an action anticoagulant potential and possibly interact with warfarin, but there are no conclusive studies about it.
The use of this medicine along with drugs inhibiting monoamine oxidase inhibitor (isocarboxazid, phenelzine, and tranylcypromine) may cause additive effect.
what to do if someone use a larger amount than is recommended?
Some of the symptoms of an overdose are sedation, decreased attention and reflexes.
In case of an overdose, discontinue use and seek medical guidance immediately.